Adagio Medical Holdings, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Kaster Deborah, was filed 18 Dec 2025.
Adagio Medical Holdings, Inc.: what insiders have been doing
Adagio Medical Holdings, Inc., classified in the Health Care sector, is a listed company. Its insiders report their share dealings to SEC (Form 4). Over the twelve months to 7 November 2026, 3 filings were filed, from 3 insiders.
Every open-market trade in the period is a purchase: 2 purchases worth €208k, from 2 insiders, and not a single sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The largest single trade was a purchase of €192k by Usen Todd, published on 15 December 2025. Among those who bought: 1 finance chief and 1 chief executive.
With 3 filings in twelve months, the company is quieter than the median of 24 filings across the 3,183 companies we follow on the same exchange. Our records for Adagio Medical Holdings, Inc. go back to 2024, with 2 purchases and no sales on the open market in total. In its latest annual report filed with the SEC (10-K, fiscal year ended 31 December 2025), the company reported net income of -25.1 m USD.
In the case of 1 purchase, another manager of the company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. The last insider purchase was made public on 18 December 2025, 326 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. US insiders must file a Form 4 within two business days of a trade.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and Vetoquinol SA. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleSince the insiders bought
- +0.0%Entry US$1.03 · Close at T+90 US$1.03
- -9.3%Entry US$1.18 · Close at T+90 US$1.07
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
- 12,770 shares0Common StockSEC:0002031256-26-000004:0
- 15,000 shares@ US$1.1982100.0% of flowCommon StockSEC:0002089223-25-000002:0Canonical exit: 16 Mar 2026 (T+90)
- 207,315 shares@ US$1.09100.0% of flowCommon StockSEC:0001964615-25-000003:0Canonical exit: 12 Mar 2026 (T+90)
- 64,167 sharesCommon StockSEC:0001062993-25-002547:0
- 3,501,600 sharesCommon StockSEC:0001140361-24-042486:0
- 22,081 sharesCommon StockSEC:0001140361-24-035441:1
- 36,698 sharesCommon StockSEC:0001140361-24-035440:0
- 7,539 sharesCommon StockSEC:0001140361-24-035442:0
- 212,053 sharesCommon StockSEC:0001140361-24-035441:0
9 of 9 declarations
About Adagio Medical Holdings, Inc.
Adagio Medical Holdings, Inc. is a company listed on the XNAS market. It specializes in developing innovative medical solutions.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
